Login / Signup

ctDNA from body fluids is an adequate source for EGFR biomarker testing in advanced lung adenocarcinoma.

Clara Pérez-BarriosEstela Sánchez-HerreroNatalia Garcia-SimónMiguel BarquínMariola Blanco ClementeMariano ProvencioAtocha Romero
Published in: Clinical chemistry and laboratory medicine (2021)
ctDNA derived from body fluids is an informative source for EGFR biomarker testing, with greater sensitivity than plasma samples.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • circulating tumor